RIGEN BIOTECH
Rijing Biosciences has launched thyroid biopsy needles, multi-gene qPCR detection and NGS detection, Thyroscan® thyroid nodule benign and malignant classifier, and targeted surgery for thyroid cancer from preoperative sampling, diagnosis, to postoperative monitoring. Full-process series products such as post-recurrence monitoring provide a variety of solutions for the entire thyroid cancer diagnosis and treatment cycle.
RIGEN BIOTECH
Social Links:
Industry:
Biotechnology Health Diagnostics Medical Device
Founded:
2017-01-01
Address:
Minhang, Shanghai, China
Country:
China
Website Url:
http://www.rigen-bio.com
Status:
Active
Contact:
1-215-825-0316
Email Addresses:
[email protected]
Total Funding:
100 M CNY
Technology used in webpage:
SPF Alibaba HiChina DNS Alibaba Cloud MailBox
Investors List
BioTrack Capital
BioTrack Capital investment in Venture Round - Rigen Biotech
Guotai Junan Innovation Investment
Guotai Junan Innovation Investment investment in Venture Round - Rigen Biotech
Yinshengtai Capital
Yinshengtai Capital investment in Venture Round - Rigen Biotech
